36 related articles for article (PubMed ID: 25899746)
1. Erratum: c-Jun mediates hepatitis C virus hepatocarcinogenesis through signal transducer and activator of transcription 3 and nitric oxide-dependent impairment of oxidative DNA repair.
Hepatology; 2024 Jul; 80(1):E21. PubMed ID: 38896075
[No Abstract] [Full Text] [Related]
2. Optimizing care of HBV infection and HBV-related HCC.
Lee SY; Nah BKY; Leo J; Koh JH; Huang DQ
Clin Liver Dis (Hoboken); 2024; 23(1):e0169. PubMed ID: 38911998
[No Abstract] [Full Text] [Related]
3. Eliminating hepatitis B by antagonizing cellular inhibitors of apoptosis.
Ebert G; Allison C; Preston S; Cooney J; Toe JG; Stutz MD; Ojaimi S; Baschuk N; Nachbur U; Torresi J; Silke J; Begley CG; Pellegrini M
Proc Natl Acad Sci U S A; 2015 May; 112(18):5803-8. PubMed ID: 25902530
[TBL] [Abstract][Full Text] [Related]
4. Cellular inhibitor of apoptosis proteins prevent clearance of hepatitis B virus.
Ebert G; Preston S; Allison C; Cooney J; Toe JG; Stutz MD; Ojaimi S; Scott HW; Baschuk N; Nachbur U; Torresi J; Chin R; Colledge D; Li X; Warner N; Revill P; Bowden S; Silke J; Begley CG; Pellegrini M
Proc Natl Acad Sci U S A; 2015 May; 112(18):5797-802. PubMed ID: 25902529
[TBL] [Abstract][Full Text] [Related]
5. Identification of HBV-MLL4 Integration and Its Molecular Basis in Chinese Hepatocellular Carcinoma.
Dong H; Zhang L; Qian Z; Zhu X; Zhu G; Chen Y; Xie X; Ye Q; Zang J; Ren Z; Ji Q
PLoS One; 2015; 10(4):e0123175. PubMed ID: 25901726
[TBL] [Abstract][Full Text] [Related]
6. The novel compound Z060228 inhibits assembly of the HBV capsid.
Guan H; Zhao G; Chen W; Wu G; Liu H; Jiang X; Li S; Wang LL
Life Sci; 2015 Jul; 133():1-7. PubMed ID: 25921762
[TBL] [Abstract][Full Text] [Related]
7. STAT3 inhibition reduces toxicity of oncolytic VSV and provides a potentially synergistic combination therapy for hepatocellular carcinoma.
Marozin S; Altomonte J; Muñoz-Álvarez KA; Rizzani A; De Toni EN; Thasler WE; Schmid RM; Ebert O
Cancer Gene Ther; 2015 Jun; 22(6):317-25. PubMed ID: 25930184
[TBL] [Abstract][Full Text] [Related]
8. Recent advance of the hepatitis B virus inhibitors: a medicinal chemistry overview.
Jia H; Rai D; Zhan P; Chen X; Jiang X; Liu X
Future Med Chem; 2015; 7(5):587-607. PubMed ID: 25921400
[TBL] [Abstract][Full Text] [Related]
9. Relation between serum quantitative HBsAg, ALT and HBV DNA levels in HBeAg negative chronic HBV infection.
Günal Ö; Barut Ş; Etikan İ; Duygu F; Tuncel U; Sünbül M
Turk J Gastroenterol; 2014 Dec; 25 Suppl 1():142-6. PubMed ID: 25910293
[TBL] [Abstract][Full Text] [Related]
10. Kahweol Induces Apoptosis in Hepatocellular Carcinoma Cells by Inhibiting the Src/mTOR/STAT3 Signaling Pathway.
Seo HY; Lee SH; Lee JH; Lee JH; Jang BK; Kim MK
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638852
[TBL] [Abstract][Full Text] [Related]
11. EGF receptor inhibitors comprehensively suppress hepatitis B virus by downregulation of STAT3 phosphorylation.
Gan CJ; Li WF; Li CN; Li LL; Zhou WY; Peng XM
Biochem Biophys Rep; 2020 Jul; 22():100763. PubMed ID: 32322693
[TBL] [Abstract][Full Text] [Related]
12. Apoptosis in liver carcinogenesis and chemotherapy.
Moreno-Càceres J; Fabregat I
Hepat Oncol; 2015 Oct; 2(4):381-397. PubMed ID: 30191019
[TBL] [Abstract][Full Text] [Related]
13. Differential association of STAT3 and HK-II expression in hepatitis B virus- and hepatitis C virus-related hepatocellular carcinoma.
Li M; Wang W; Jin R; Zhang T; Li N; Han Q; Wei P; Liu Z
J Med Virol; 2016 Sep; 88(9):1552-9. PubMed ID: 26889748
[TBL] [Abstract][Full Text] [Related]
14. [Correlation between androgen receptor expression and hepatitis B virus X protein and its clinical significance in hepatocellular carcinoma].
Gu DH; Zhu YZ; Wang X; Bai ZC; Ping JL; Chen Q; Zhu R
Zhonghua Zhong Liu Za Zhi; 2013 Apr; 35(4):282-7. PubMed ID: 23985257
[TBL] [Abstract][Full Text] [Related]
15. The collagen triple helix repeat containing 1 facilitates hepatitis B virus-associated hepatocellular carcinoma progression by regulating multiple cellular factors and signal cascades.
Zhang R; Cao Y; Bai L; Zhu C; Li R; He H; Liu Y; Wu K; Liu F; Wu J
Mol Carcinog; 2015 Dec; 54(12):1554-66. PubMed ID: 25263696
[TBL] [Abstract][Full Text] [Related]
16. Targeting blockage of STAT3 inhibits hepatitis B virus-related hepatocellular carcinoma.
Yang Y; Zheng B; Han Q; Zhang C; Tian Z; Zhang J
Cancer Biol Ther; 2016 Apr; 17(4):449-56. PubMed ID: 26934469
[TBL] [Abstract][Full Text] [Related]
17. Potential role of signal transducer and activator of transcription (STAT)3 signaling pathway in inflammation, survival, proliferation and invasion of hepatocellular carcinoma.
Subramaniam A; Shanmugam MK; Perumal E; Li F; Nachiyappan A; Dai X; Swamy SN; Ahn KS; Kumar AP; Tan BK; Hui KM; Sethi G
Biochim Biophys Acta; 2013 Jan; 1835(1):46-60. PubMed ID: 23103770
[TBL] [Abstract][Full Text] [Related]
18. Differences in antiproliferative effect of STAT3 inhibition in HCC cells with versus without HBV expression.
Hong Y; Zhou L; Xie H; Wang W; Zheng S
Biochem Biophys Res Commun; 2015 Jun; 461(3):513-8. PubMed ID: 25899746
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
